Drug & Medical Device Litigation

2024 has been a pivotal year for drug and medical device litigation, marked by significant case law developments that have reshaped the landscape. Landmark decisions, evidentiary amendments and advancements in technology have significantly altered the strategic planning and outlook for product liability practitioners as we transition into 2025.

As such, it is critical to stay abreast of these continuing changes and adapt to the new policies, tools and rulings that will impact outside counsel and in-house counsel for drug and device manufacturers. Be sure to join us for this insightful webinar as our in-house leaders and 2024 conference co-chairs explore these critical changes, dissect their real-world implications, and forecast their influence on future litigation trends and strategies.

Topics for discussion include:

• Unpacking the transformative Rule 702 amendments
• Harnessing AI in your legal practice and trial strategy
• Crafting innovative exit strategies for complex cases
• Mastering the art of defeating reptile theory in court
• Streamlining and clarifying MDL processes and procedures
• Forecasting and prioritizing key litigation trends for 2025